Reunió 20/10/2020
Lípid de referencia: PI 34:1
Resultats PI 34:1 Tumor Low vs Tumor High
Cluster Sample
Determinació Beta
Cluster gens
Correlació mòduls i fenotips
Gens drivers dels mòduls associats al fenotip
GO
Es mostren els 10 millors GO
| X | module | size | p.val | Bonf | nInTerm | GO.id | ont | term.name |
|---|---|---|---|---|---|---|---|---|
| 1 | bisque4 | 34 | 1.8e-03 | 1.00 | 2 | GO:0010656 | BP | negative regulation of muscle cell apoptotic process |
| 2 | bisque4 | 34 | 2.4e-03 | 1.00 | 2 | GO:0016235 | CC | aggresome |
| 3 | bisque4 | 34 | 2.7e-03 | 1.00 | 1 | GO:0001552 | BP | ovarian follicle atresia |
| 4 | bisque4 | 34 | 2.7e-03 | 1.00 | 1 | GO:0015782 | BP | CMP-N-acetylneuraminate transmembrane transport |
| 5 | bisque4 | 34 | 2.7e-03 | 1.00 | 1 | GO:1902530 | BP | positive regulation of protein linear polyubiquitination |
| 6 | bisque4 | 34 | 2.7e-03 | 1.00 | 1 | GO:2000355 | BP | negative regulation of ovarian follicle development |
| 7 | bisque4 | 34 | 2.7e-03 | 1.00 | 1 | GO:0001536 | CC | radial spoke stalk |
| 8 | bisque4 | 34 | 2.7e-03 | 1.00 | 1 | GO:0004632 | MF | phosphopantothenate–cysteine ligase activity |
| 9 | bisque4 | 34 | 2.7e-03 | 1.00 | 1 | GO:0005456 | MF | CMP-N-acetylneuraminate transmembrane transporter activity |
| 10 | bisque4 | 34 | 2.7e-03 | 1.00 | 1 | GO:0033906 | MF | hyaluronoglucuronidase activity |
| 11 | black | 442 | 1.1e-04 | 1.00 | 4 | GO:0016139 | BP | glycoside catabolic process |
| 12 | black | 442 | 1.8e-04 | 1.00 | 3 | GO:0050904 | BP | diapedesis |
| 13 | black | 442 | 1.9e-04 | 1.00 | 20 | GO:0051271 | BP | negative regulation of cellular component movement |
| 14 | black | 442 | 4.3e-04 | 1.00 | 19 | GO:0040013 | BP | negative regulation of locomotion |
| 15 | black | 442 | 4.5e-04 | 1.00 | 3 | GO:0038026 | BP | reelin-mediated signaling pathway |
| 16 | black | 442 | 7.0e-04 | 1.00 | 7 | GO:0001885 | BP | endothelial cell development |
| 17 | black | 442 | 9.2e-04 | 1.00 | 17 | GO:2000146 | BP | negative regulation of cell motility |
| 18 | black | 442 | 1.2e-03 | 1.00 | 8 | GO:0004553 | MF | hydrolase activity, hydrolyzing O-glycosyl compounds |
| 19 | black | 442 | 1.2e-03 | 1.00 | 19 | GO:0043687 | BP | post-translational protein modification |
| 20 | black | 442 | 1.3e-03 | 1.00 | 2 | GO:0035685 | BP | helper T cell diapedesis |
| 21 | blue | 1046 | 1.7e-05 | 0.31 | 9 | GO:0005343 | MF | organic acid:sodium symporter activity |
| 22 | blue | 1046 | 1.4e-04 | 1.00 | 22 | GO:0042582 | CC | azurophil granule |
| 23 | blue | 1046 | 2.5e-04 | 1.00 | 4 | GO:0015129 | MF | lactate transmembrane transporter activity |
| 24 | blue | 1046 | 4.3e-04 | 1.00 | 5 | GO:0070016 | MF | armadillo repeat domain binding |
| 25 | blue | 1046 | 5.4e-04 | 1.00 | 18 | GO:0007498 | BP | mesoderm development |
| 26 | blue | 1046 | 5.7e-04 | 1.00 | 23 | GO:0007369 | BP | gastrulation |
| 27 | blue | 1046 | 7.0e-04 | 1.00 | 4 | GO:0015727 | BP | lactate transport |
| 28 | blue | 1046 | 7.0e-04 | 1.00 | 4 | GO:0035873 | BP | lactate transmembrane transport |
| 29 | blue | 1046 | 7.0e-04 | 1.00 | 4 | GO:0071204 | CC | histone pre-mRNA 3’end processing complex |
| 30 | blue | 1046 | 1.2e-03 | 1.00 | 17 | GO:0001704 | BP | formation of primary germ layer |
| 31 | brown | 897 | 3.9e-04 | 1.00 | 3 | GO:0015087 | MF | cobalt ion transmembrane transporter activity |
| 32 | brown | 897 | 5.5e-04 | 1.00 | 30 | GO:0019898 | CC | extrinsic component of membrane |
| 33 | brown | 897 | 8.4e-04 | 1.00 | 4 | GO:0006600 | BP | creatine metabolic process |
| 34 | brown | 897 | 8.4e-04 | 1.00 | 4 | GO:0051400 | MF | BH domain binding |
| 35 | brown | 897 | 8.4e-04 | 1.00 | 4 | GO:0051880 | MF | G-quadruplex DNA binding |
| 36 | brown | 897 | 9.0e-04 | 1.00 | 9 | GO:0043195 | CC | terminal bouton |
| 37 | brown | 897 | 9.1e-04 | 1.00 | 15 | GO:0007569 | BP | cell aging |
| 38 | brown | 897 | 1.1e-03 | 1.00 | 45 | GO:0007507 | BP | heart development |
| 39 | brown | 897 | 1.4e-03 | 1.00 | 8 | GO:0048538 | BP | thymus development |
| 40 | brown | 897 | 1.5e-03 | 1.00 | 3 | GO:0090230 | BP | regulation of centromere complex assembly |
| 41 | brown4 | 39 | 1.0e-04 | 1.00 | 2 | GO:0050859 | BP | negative regulation of B cell receptor signaling pathway |
| 42 | brown4 | 39 | 2.1e-04 | 1.00 | 2 | GO:0000183 | BP | rDNA heterochromatin assembly |
| 43 | brown4 | 39 | 2.1e-04 | 1.00 | 2 | GO:0070679 | MF | inositol 1,4,5 trisphosphate binding |
| 44 | brown4 | 39 | 4.5e-04 | 1.00 | 2 | GO:0043652 | BP | engulfment of apoptotic cell |
| 45 | brown4 | 39 | 5.5e-04 | 1.00 | 2 | GO:0032809 | CC | neuronal cell body membrane |
| 46 | brown4 | 39 | 7.8e-04 | 1.00 | 2 | GO:0044298 | CC | cell body membrane |
| 47 | brown4 | 39 | 1.3e-03 | 1.00 | 2 | GO:0042044 | BP | fluid transport |
| 48 | brown4 | 39 | 1.7e-03 | 1.00 | 2 | GO:0050849 | BP | negative regulation of calcium-mediated signaling |
| 49 | brown4 | 39 | 1.7e-03 | 1.00 | 2 | GO:0050855 | BP | regulation of B cell receptor signaling pathway |
| 50 | brown4 | 39 | 3.2e-03 | 1.00 | 1 | GO:0009956 | BP | radial pattern formation |
| 51 | cyan | 230 | 3.6e-04 | 1.00 | 2 | GO:0099074 | BP | mitochondrion to lysosome transport |
| 52 | cyan | 230 | 2.1e-03 | 1.00 | 3 | GO:0098969 | BP | neurotransmitter receptor transport to postsynaptic membrane |
| 53 | cyan | 230 | 2.1e-03 | 1.00 | 3 | GO:1903540 | BP | establishment of protein localization to postsynaptic membrane |
| 54 | cyan | 230 | 2.1e-03 | 1.00 | 2 | GO:0048408 | MF | epidermal growth factor binding |
| 55 | cyan | 230 | 2.9e-03 | 1.00 | 5 | GO:0042562 | MF | hormone binding |
| 56 | cyan | 230 | 3.1e-03 | 1.00 | 8 | GO:0004721 | MF | phosphoprotein phosphatase activity |
| 57 | cyan | 230 | 3.2e-03 | 1.00 | 5 | GO:0035418 | BP | protein localization to synapse |
| 58 | cyan | 230 | 3.4e-03 | 1.00 | 2 | GO:1901142 | BP | insulin metabolic process |
| 59 | cyan | 230 | 3.7e-03 | 1.00 | 4 | GO:0097120 | BP | receptor localization to synapse |
| 60 | cyan | 230 | 4.1e-03 | 1.00 | 4 | GO:0006120 | BP | mitochondrial electron transport, NADH to ubiquinone |
| 61 | darkgreen | 140 | 1.3e-04 | 1.00 | 2 | GO:1905642 | BP | negative regulation of DNA methylation |
| 62 | darkgreen | 140 | 7.9e-04 | 1.00 | 2 | GO:1900425 | BP | negative regulation of defense response to bacterium |
| 63 | darkgreen | 140 | 2.1e-03 | 1.00 | 6 | GO:0010212 | BP | response to ionizing radiation |
| 64 | darkgreen | 140 | 2.2e-03 | 1.00 | 20 | GO:0060429 | BP | epithelium development |
| 65 | darkgreen | 140 | 2.7e-03 | 1.00 | 2 | GO:0015937 | BP | coenzyme A biosynthetic process |
| 66 | darkgreen | 140 | 2.7e-03 | 1.00 | 2 | GO:0090557 | BP | establishment of endothelial intestinal barrier |
| 67 | darkgreen | 140 | 3.0e-03 | 1.00 | 4 | GO:0071479 | BP | cellular response to ionizing radiation |
| 68 | darkgreen | 140 | 3.2e-03 | 1.00 | 8 | GO:0048511 | BP | rhythmic process |
| 69 | darkgreen | 140 | 3.2e-03 | 1.00 | 3 | GO:0042908 | BP | xenobiotic transport |
| 70 | darkgreen | 140 | 3.6e-03 | 1.00 | 2 | GO:0001865 | BP | NK T cell differentiation |
| 71 | darkgrey | 118 | 1.2e-04 | 1.00 | 5 | GO:0042054 | MF | histone methyltransferase activity |
| 72 | darkgrey | 118 | 1.9e-04 | 1.00 | 3 | GO:2000251 | BP | positive regulation of actin cytoskeleton reorganization |
| 73 | darkgrey | 118 | 2.9e-04 | 1.00 | 2 | GO:0009298 | BP | GDP-mannose biosynthetic process |
| 74 | darkgrey | 118 | 4.4e-04 | 1.00 | 5 | GO:0008276 | MF | protein methyltransferase activity |
| 75 | darkgrey | 118 | 5.7e-04 | 1.00 | 4 | GO:0018024 | MF | histone-lysine N-methyltransferase activity |
| 76 | darkgrey | 118 | 5.7e-04 | 1.00 | 2 | GO:0070568 | MF | guanylyltransferase activity |
| 77 | darkgrey | 118 | 6.9e-04 | 1.00 | 6 | GO:0016571 | BP | histone methylation |
| 78 | darkgrey | 118 | 6.9e-04 | 1.00 | 3 | GO:0018027 | BP | peptidyl-lysine dimethylation |
| 79 | darkgrey | 118 | 7.1e-04 | 1.00 | 5 | GO:0008170 | MF | N-methyltransferase activity |
| 80 | darkgrey | 118 | 9.0e-04 | 1.00 | 4 | GO:0016279 | MF | protein-lysine N-methyltransferase activity |
| 81 | darkmagenta | 65 | 5.0e-04 | 1.00 | 5 | GO:0071346 | BP | cellular response to interferon-gamma |
| 82 | darkmagenta | 65 | 9.4e-04 | 1.00 | 5 | GO:0034341 | BP | response to interferon-gamma |
| 83 | darkmagenta | 65 | 1.0e-03 | 1.00 | 5 | GO:0030100 | BP | regulation of endocytosis |
| 84 | darkmagenta | 65 | 1.1e-03 | 1.00 | 5 | GO:0046890 | BP | regulation of lipid biosynthetic process |
| 85 | darkmagenta | 65 | 1.3e-03 | 1.00 | 7 | GO:0019216 | BP | regulation of lipid metabolic process |
| 86 | darkmagenta | 65 | 1.4e-03 | 1.00 | 4 | GO:0019218 | BP | regulation of steroid metabolic process |
| 87 | darkmagenta | 65 | 2.0e-03 | 1.00 | 3 | GO:0090181 | BP | regulation of cholesterol metabolic process |
| 88 | darkmagenta | 65 | 2.5e-03 | 1.00 | 2 | GO:0030904 | CC | retromer complex |
| 89 | darkmagenta | 65 | 3.7e-03 | 1.00 | 7 | GO:0006897 | BP | endocytosis |
| 90 | darkmagenta | 65 | 4.2e-03 | 1.00 | 4 | GO:0006633 | BP | fatty acid biosynthetic process |
| 91 | darkolivegreen | 81 | 1.4e-04 | 1.00 | 2 | GO:0071211 | BP | protein targeting to vacuole involved in autophagy |
| 92 | darkolivegreen | 81 | 2.3e-04 | 1.00 | 3 | GO:0061615 | BP | glycolytic process through fructose-6-phosphate |
| 93 | darkolivegreen | 81 | 2.3e-04 | 1.00 | 3 | GO:0061621 | BP | canonical glycolysis |
| 94 | darkolivegreen | 81 | 4.3e-04 | 1.00 | 3 | GO:0045910 | BP | negative regulation of DNA recombination |
| 95 | darkolivegreen | 81 | 6.3e-04 | 1.00 | 3 | GO:0006007 | BP | glucose catabolic process |
| 96 | darkolivegreen | 81 | 6.4e-04 | 1.00 | 4 | GO:0070062 | CC | extracellular exosome |
| 97 | darkolivegreen | 81 | 6.7e-04 | 1.00 | 2 | GO:0070847 | CC | core mediator complex |
| 98 | darkolivegreen | 81 | 6.7e-04 | 1.00 | 2 | GO:0015280 | MF | ligand-gated sodium channel activity |
| 99 | darkolivegreen | 81 | 8.8e-04 | 1.00 | 3 | GO:0006734 | BP | NADH metabolic process |
| 100 | darkolivegreen | 81 | 1.0e-03 | 1.00 | 4 | GO:1903561 | CC | extracellular vesicle |
| 101 | darkorange | 111 | 1.4e-04 | 1.00 | 5 | GO:0070491 | MF | repressing transcription factor binding |
| 102 | darkorange | 111 | 2.5e-04 | 1.00 | 10 | GO:0052548 | BP | regulation of endopeptidase activity |
| 103 | darkorange | 111 | 4.2e-04 | 1.00 | 10 | GO:0052547 | BP | regulation of peptidase activity |
| 104 | darkorange | 111 | 4.8e-04 | 1.00 | 3 | GO:0001530 | MF | lipopolysaccharide binding |
| 105 | darkorange | 111 | 5.1e-04 | 1.00 | 2 | GO:0000455 | BP | enzyme-directed rRNA pseudouridine synthesis |
| 106 | darkorange | 111 | 5.1e-04 | 1.00 | 2 | GO:0034186 | MF | apolipoprotein A-I binding |
| 107 | darkorange | 111 | 1.0e-03 | 1.00 | 4 | GO:0009142 | BP | nucleoside triphosphate biosynthetic process |
| 108 | darkorange | 111 | 1.2e-03 | 1.00 | 2 | GO:0031118 | BP | rRNA pseudouridine synthesis |
| 109 | darkorange | 111 | 1.2e-03 | 1.00 | 2 | GO:0004017 | MF | adenylate kinase activity |
| 110 | darkorange | 111 | 2.1e-03 | 1.00 | 3 | GO:1904837 | BP | beta-catenin-TCF complex assembly |
| 111 | darkorange2 | 41 | 1.3e-03 | 1.00 | 2 | GO:0034364 | CC | high-density lipoprotein particle |
| 112 | darkorange2 | 41 | 2.7e-03 | 1.00 | 2 | GO:0034358 | CC | plasma lipoprotein particle |
| 113 | darkorange2 | 41 | 2.7e-03 | 1.00 | 2 | GO:1990777 | CC | lipoprotein particle |
| 114 | darkorange2 | 41 | 3.4e-03 | 1.00 | 1 | GO:0007493 | BP | endodermal cell fate determination |
| 115 | darkorange2 | 41 | 3.4e-03 | 1.00 | 1 | GO:0019449 | BP | L-cysteine catabolic process to hypotaurine |
| 116 | darkorange2 | 41 | 3.4e-03 | 1.00 | 1 | GO:0019452 | BP | L-cysteine catabolic process to taurine |
| 117 | darkorange2 | 41 | 3.4e-03 | 1.00 | 1 | GO:0042412 | BP | taurine biosynthetic process |
| 118 | darkorange2 | 41 | 3.4e-03 | 1.00 | 1 | GO:0061301 | BP | cerebellum vasculature morphogenesis |
| 119 | darkorange2 | 41 | 3.4e-03 | 1.00 | 1 | GO:0061741 | BP | chaperone-mediated protein transport involved in chaperone-mediated autophagy |
| 120 | darkorange2 | 41 | 3.4e-03 | 1.00 | 1 | GO:1902847 | BP | regulation of neuronal signal transduction |
| 121 | darkred | 171 | 1.7e-04 | 1.00 | 5 | GO:0070534 | BP | protein K63-linked ubiquitination |
| 122 | darkred | 171 | 1.7e-04 | 1.00 | 5 | GO:0015935 | CC | small ribosomal subunit |
| 123 | darkred | 171 | 5.8e-04 | 1.00 | 2 | GO:0043622 | BP | cortical microtubule organization |
| 124 | darkred | 171 | 5.8e-04 | 1.00 | 2 | GO:0060232 | BP | delamination |
| 125 | darkred | 171 | 5.8e-04 | 1.00 | 2 | GO:2000340 | BP | positive regulation of chemokine (C-X-C motif) ligand 1 production |
| 126 | darkred | 171 | 1.1e-03 | 1.00 | 2 | GO:0071651 | BP | positive regulation of chemokine (C-C motif) ligand 5 production |
| 127 | darkred | 171 | 1.4e-03 | 1.00 | 5 | GO:0070126 | BP | mitochondrial translational termination |
| 128 | darkred | 171 | 1.5e-03 | 1.00 | 7 | GO:0005840 | CC | ribosome |
| 129 | darkred | 171 | 1.6e-03 | 1.00 | 3 | GO:0030033 | BP | microvillus assembly |
| 130 | darkred | 171 | 1.9e-03 | 1.00 | 2 | GO:0030242 | BP | autophagy of peroxisome |
| 131 | darkslateblue | 38 | 9.1e-05 | 1.00 | 2 | GO:0006528 | BP | asparagine metabolic process |
| 132 | darkslateblue | 38 | 7.0e-04 | 1.00 | 2 | GO:0033194 | BP | response to hydroperoxide |
| 133 | darkslateblue | 38 | 1.1e-03 | 1.00 | 2 | GO:0035743 | BP | CD4-positive, alpha-beta T cell cytokine production |
| 134 | darkslateblue | 38 | 1.5e-03 | 1.00 | 2 | GO:0006607 | BP | NLS-bearing protein import into nucleus |
| 135 | darkslateblue | 38 | 1.7e-03 | 1.00 | 3 | GO:0000079 | BP | regulation of cyclin-dependent protein serine/threonine kinase activity |
| 136 | darkslateblue | 38 | 3.1e-03 | 1.00 | 1 | GO:0007072 | BP | positive regulation of transcription involved in exit from mitosis |
| 137 | darkslateblue | 38 | 3.1e-03 | 1.00 | 1 | GO:0007624 | BP | ultradian rhythm |
| 138 | darkslateblue | 38 | 3.1e-03 | 1.00 | 1 | GO:0021757 | BP | caudate nucleus development |
| 139 | darkslateblue | 38 | 3.1e-03 | 1.00 | 1 | GO:0021758 | BP | putamen development |
| 140 | darkslateblue | 38 | 3.1e-03 | 1.00 | 1 | GO:0033345 | BP | asparagine catabolic process via L-aspartate |
| 141 | darkturquoise | 126 | 2.1e-03 | 1.00 | 2 | GO:2000049 | BP | positive regulation of cell-cell adhesion mediated by cadherin |
| 142 | darkturquoise | 126 | 3.6e-03 | 1.00 | 2 | GO:0072687 | CC | meiotic spindle |
| 143 | darkturquoise | 126 | 3.6e-03 | 1.00 | 2 | GO:0008191 | MF | metalloendopeptidase inhibitor activity |
| 144 | darkturquoise | 126 | 4.9e-03 | 1.00 | 5 | GO:0031123 | BP | RNA 3’-end processing |
| 145 | darkturquoise | 126 | 5.7e-03 | 1.00 | 6 | GO:0015291 | MF | secondary active transmembrane transporter activity |
| 146 | darkturquoise | 126 | 6.9e-03 | 1.00 | 5 | GO:0051028 | BP | mRNA transport |
| 147 | darkturquoise | 126 | 8.6e-03 | 1.00 | 4 | GO:1904659 | BP | glucose transmembrane transport |
| 148 | darkturquoise | 126 | 8.7e-03 | 1.00 | 2 | GO:0043931 | BP | ossification involved in bone maturation |
| 149 | darkturquoise | 126 | 9.0e-03 | 1.00 | 22 | GO:0042592 | BP | homeostatic process |
| 150 | darkturquoise | 126 | 9.4e-03 | 1.00 | 4 | GO:0019955 | MF | cytokine binding |
| 151 | floralwhite | 46 | 5.1e-04 | 1.00 | 2 | GO:0090533 | CC | cation-transporting ATPase complex |
| 152 | floralwhite | 46 | 9.2e-04 | 1.00 | 2 | GO:0071732 | BP | cellular response to nitric oxide |
| 153 | floralwhite | 46 | 1.3e-03 | 1.00 | 2 | GO:0071731 | BP | response to nitric oxide |
| 154 | floralwhite | 46 | 1.5e-03 | 1.00 | 2 | GO:1902170 | BP | cellular response to reactive nitrogen species |
| 155 | floralwhite | 46 | 3.8e-03 | 1.00 | 1 | GO:0010814 | BP | substance P catabolic process |
| 156 | floralwhite | 46 | 3.8e-03 | 1.00 | 1 | GO:0010816 | BP | calcitonin catabolic process |
| 157 | floralwhite | 46 | 3.8e-03 | 1.00 | 1 | GO:0034474 | BP | U2 snRNA 3’-end processing |
| 158 | floralwhite | 46 | 3.8e-03 | 1.00 | 1 | GO:0034959 | BP | endothelin maturation |
| 159 | floralwhite | 46 | 3.8e-03 | 1.00 | 1 | GO:0060404 | BP | axonemal microtubule depolymerization |
| 160 | floralwhite | 46 | 3.8e-03 | 1.00 | 1 | GO:0070462 | BP | plus-end specific microtubule depolymerization |
| 161 | green | 745 | 1.8e-04 | 1.00 | 12 | GO:0031397 | BP | negative regulation of protein ubiquitination |
| 162 | green | 745 | 1.8e-04 | 1.00 | 8 | GO:0034405 | BP | response to fluid shear stress |
| 163 | green | 745 | 2.7e-04 | 1.00 | 5 | GO:0033127 | BP | regulation of histone phosphorylation |
| 164 | green | 745 | 4.2e-04 | 1.00 | 27 | GO:0006260 | BP | DNA replication |
| 165 | green | 745 | 5.5e-04 | 1.00 | 59 | GO:0009725 | BP | response to hormone |
| 166 | green | 745 | 7.6e-04 | 1.00 | 9 | GO:0005518 | MF | collagen binding |
| 167 | green | 745 | 7.7e-04 | 1.00 | 4 | GO:0033129 | BP | positive regulation of histone phosphorylation |
| 168 | green | 745 | 8.3e-04 | 1.00 | 18 | GO:0071248 | BP | cellular response to metal ion |
| 169 | green | 745 | 9.0e-04 | 1.00 | 6 | GO:1902254 | BP | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| 170 | green | 745 | 1.0e-03 | 1.00 | 22 | GO:0001818 | BP | negative regulation of cytokine production |
| 171 | greenyellow | 360 | 5.8e-04 | 1.00 | 4 | GO:0018149 | BP | peptide cross-linking |
| 172 | greenyellow | 360 | 7.8e-04 | 1.00 | 6 | GO:0042771 | BP | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| 173 | greenyellow | 360 | 7.8e-04 | 1.00 | 4 | GO:1902166 | BP | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| 174 | greenyellow | 360 | 8.6e-04 | 1.00 | 2 | GO:0045163 | BP | clustering of voltage-gated potassium channels |
| 175 | greenyellow | 360 | 8.6e-04 | 1.00 | 2 | GO:0000254 | MF | C-4 methylsterol oxidase activity |
| 176 | greenyellow | 360 | 1.0e-03 | 1.00 | 4 | GO:1902165 | BP | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| 177 | greenyellow | 360 | 1.0e-03 | 1.00 | 6 | GO:0071005 | CC | U2-type precatalytic spliceosome |
| 178 | greenyellow | 360 | 1.2e-03 | 1.00 | 6 | GO:0042267 | BP | natural killer cell mediated cytotoxicity |
| 179 | greenyellow | 360 | 1.3e-03 | 1.00 | 3 | GO:2001187 | BP | positive regulation of CD8-positive, alpha-beta T cell activation |
| 180 | greenyellow | 360 | 1.3e-03 | 1.00 | 4 | GO:0035493 | BP | SNARE complex assembly |
| 181 | grey | 33 | 1.4e-03 | 1.00 | 4 | GO:0007411 | BP | axon guidance |
| 182 | grey | 33 | 1.4e-03 | 1.00 | 4 | GO:0097485 | BP | neuron projection guidance |
| 183 | grey | 33 | 2.7e-03 | 1.00 | 1 | GO:0001315 | BP | age-dependent response to reactive oxygen species |
| 184 | grey | 33 | 2.7e-03 | 1.00 | 1 | GO:0003069 | BP | acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure |
| 185 | grey | 33 | 2.7e-03 | 1.00 | 1 | GO:1905932 | BP | positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching |
| 186 | grey | 33 | 4.3e-03 | 1.00 | 2 | GO:0045815 | BP | positive regulation of gene expression, epigenetic |
| 187 | grey | 33 | 5.4e-03 | 1.00 | 1 | GO:1902044 | BP | regulation of Fas signaling pathway |
| 188 | grey | 33 | 5.4e-03 | 1.00 | 1 | GO:0031213 | CC | RSF complex |
| 189 | grey | 33 | 6.6e-03 | 1.00 | 2 | GO:0010257 | BP | NADH dehydrogenase complex assembly |
| 190 | grey | 33 | 6.6e-03 | 1.00 | 2 | GO:0032507 | BP | maintenance of protein location in cell |
| 191 | grey60 | 193 | 9.0e-05 | 1.00 | 8 | GO:0044306 | CC | neuron projection terminus |
| 192 | grey60 | 193 | 2.0e-04 | 1.00 | 3 | GO:0030207 | BP | chondroitin sulfate catabolic process |
| 193 | grey60 | 193 | 2.3e-04 | 1.00 | 5 | GO:0043195 | CC | terminal bouton |
| 194 | grey60 | 193 | 2.4e-04 | 1.00 | 7 | GO:0043679 | CC | axon terminus |
| 195 | grey60 | 193 | 1.4e-03 | 1.00 | 2 | GO:0021707 | BP | cerebellar granule cell differentiation |
| 196 | grey60 | 193 | 1.5e-03 | 1.00 | 4 | GO:0060076 | CC | excitatory synapse |
| 197 | grey60 | 193 | 3.2e-03 | 1.00 | 4 | GO:0008375 | MF | acetylglucosaminyltransferase activity |
| 198 | grey60 | 193 | 3.5e-03 | 1.00 | 2 | GO:0021683 | BP | cerebellar granular layer morphogenesis |
| 199 | grey60 | 193 | 4.1e-03 | 1.00 | 3 | GO:0001891 | CC | phagocytic cup |
| 200 | grey60 | 193 | 4.7e-03 | 1.00 | 6 | GO:0008194 | MF | UDP-glycosyltransferase activity |
| 201 | ivory | 45 | 2.5e-04 | 1.00 | 3 | GO:0030042 | BP | actin filament depolymerization |
| 202 | ivory | 45 | 3.4e-04 | 1.00 | 25 | GO:0048856 | BP | anatomical structure development |
| 203 | ivory | 45 | 6.6e-04 | 1.00 | 3 | GO:0007218 | BP | neuropeptide signaling pathway |
| 204 | ivory | 45 | 7.0e-04 | 1.00 | 2 | GO:0045945 | BP | positive regulation of transcription by RNA polymerase III |
| 205 | ivory | 45 | 8.5e-04 | 1.00 | 9 | GO:0007167 | BP | enzyme linked receptor protein signaling pathway |
| 206 | ivory | 45 | 9.0e-04 | 1.00 | 6 | GO:0098793 | CC | presynapse |
| 207 | ivory | 45 | 9.9e-04 | 1.00 | 3 | GO:0030510 | BP | regulation of BMP signaling pathway |
| 208 | ivory | 45 | 1.2e-03 | 1.00 | 7 | GO:0071363 | BP | cellular response to growth factor stimulus |
| 209 | ivory | 45 | 1.4e-03 | 1.00 | 25 | GO:0032502 | BP | developmental process |
| 210 | ivory | 45 | 1.5e-03 | 1.00 | 2 | GO:0051930 | BP | regulation of sensory perception of pain |
| 211 | lightcyan | 232 | 1.4e-04 | 1.00 | 3 | GO:0070324 | MF | thyroid hormone binding |
| 212 | lightcyan | 232 | 2.4e-04 | 1.00 | 3 | GO:0042541 | BP | hemoglobin biosynthetic process |
| 213 | lightcyan | 232 | 5.6e-04 | 1.00 | 3 | GO:0020027 | BP | hemoglobin metabolic process |
| 214 | lightcyan | 232 | 9.1e-04 | 1.00 | 4 | GO:0048821 | BP | erythrocyte development |
| 215 | lightcyan | 232 | 1.1e-03 | 1.00 | 2 | GO:0006808 | BP | regulation of nitrogen utilization |
| 216 | lightcyan | 232 | 1.1e-03 | 1.00 | 2 | GO:0046666 | BP | retinal cell programmed cell death |
| 217 | lightcyan | 232 | 1.1e-03 | 1.00 | 2 | GO:0046985 | BP | positive regulation of hemoglobin biosynthetic process |
| 218 | lightcyan | 232 | 1.3e-03 | 1.00 | 8 | GO:0070820 | CC | tertiary granule |
| 219 | lightcyan | 232 | 3.3e-03 | 1.00 | 3 | GO:0043032 | BP | positive regulation of macrophage activation |
| 220 | lightcyan | 232 | 3.6e-03 | 1.00 | 2 | GO:0002154 | BP | thyroid hormone mediated signaling pathway |
| 221 | lightcyan1 | 50 | 1.8e-04 | 1.00 | 5 | GO:0007219 | BP | Notch signaling pathway |
| 222 | lightcyan1 | 50 | 2.5e-04 | 1.00 | 2 | GO:2000271 | BP | positive regulation of fibroblast apoptotic process |
| 223 | lightcyan1 | 50 | 2.8e-04 | 1.00 | 29 | GO:0023052 | BP | signaling |
| 224 | lightcyan1 | 50 | 2.8e-04 | 1.00 | 3 | GO:0035329 | BP | hippo signaling |
| 225 | lightcyan1 | 50 | 3.1e-04 | 1.00 | 29 | GO:0007154 | BP | cell communication |
| 226 | lightcyan1 | 50 | 4.7e-04 | 1.00 | 27 | GO:0007165 | BP | signal transduction |
| 227 | lightcyan1 | 50 | 9.1e-04 | 1.00 | 2 | GO:0005338 | MF | nucleotide-sugar transmembrane transporter activity |
| 228 | lightcyan1 | 50 | 1.0e-03 | 1.00 | 18 | GO:0009966 | BP | regulation of signal transduction |
| 229 | lightcyan1 | 50 | 1.1e-03 | 1.00 | 13 | GO:1902531 | BP | regulation of intracellular signal transduction |
| 230 | lightcyan1 | 50 | 1.3e-03 | 1.00 | 2 | GO:0036065 | BP | fucosylation |
| 231 | lightgreen | 185 | 1.7e-04 | 1.00 | 7 | GO:0000777 | CC | condensed chromosome kinetochore |
| 232 | lightgreen | 185 | 2.1e-04 | 1.00 | 22 | GO:0099512 | CC | supramolecular fiber |
| 233 | lightgreen | 185 | 2.1e-04 | 1.00 | 8 | GO:0000776 | CC | kinetochore |
| 234 | lightgreen | 185 | 3.8e-04 | 1.00 | 7 | GO:0000779 | CC | condensed chromosome, centromeric region |
| 235 | lightgreen | 185 | 5.1e-04 | 1.00 | 9 | GO:0000775 | CC | chromosome, centromeric region |
| 236 | lightgreen | 185 | 7.2e-04 | 1.00 | 2 | GO:1990423 | CC | RZZ complex |
| 237 | lightgreen | 185 | 8.7e-04 | 1.00 | 4 | GO:0015026 | MF | coreceptor activity |
| 238 | lightgreen | 185 | 9.7e-04 | 1.00 | 9 | GO:0000793 | CC | condensed chromosome |
| 239 | lightgreen | 185 | 1.4e-03 | 1.00 | 2 | GO:0005947 | CC | mitochondrial alpha-ketoglutarate dehydrogenase complex |
| 240 | lightgreen | 185 | 1.4e-03 | 1.00 | 2 | GO:0097443 | CC | sorting endosome |
| 241 | lightsteelblue1 | 47 | 7.1e-04 | 1.00 | 3 | GO:0061512 | BP | protein localization to cilium |
| 242 | lightsteelblue1 | 47 | 1.3e-03 | 1.00 | 2 | GO:0015278 | MF | calcium-release channel activity |
| 243 | lightsteelblue1 | 47 | 1.5e-03 | 1.00 | 3 | GO:0051668 | BP | localization within membrane |
| 244 | lightsteelblue1 | 47 | 1.5e-03 | 1.00 | 2 | GO:0050857 | BP | positive regulation of antigen receptor-mediated signaling pathway |
| 245 | lightsteelblue1 | 47 | 2.3e-03 | 1.00 | 5 | GO:0046873 | MF | metal ion transmembrane transporter activity |
| 246 | lightsteelblue1 | 47 | 2.5e-03 | 1.00 | 3 | GO:0005262 | MF | calcium channel activity |
| 247 | lightsteelblue1 | 47 | 3.0e-03 | 1.00 | 2 | GO:0099604 | MF | ligand-gated calcium channel activity |
| 248 | lightsteelblue1 | 47 | 3.2e-03 | 1.00 | 3 | GO:0051209 | BP | release of sequestered calcium ion into cytosol |
| 249 | lightsteelblue1 | 47 | 3.4e-03 | 1.00 | 3 | GO:0051283 | BP | negative regulation of sequestering of calcium ion |
| 250 | lightsteelblue1 | 47 | 3.5e-03 | 1.00 | 3 | GO:0051282 | BP | regulation of sequestering of calcium ion |
| 251 | lightyellow | 171 | 1.9e-04 | 1.00 | 3 | GO:0050700 | MF | CARD domain binding |
| 252 | lightyellow | 171 | 5.4e-04 | 1.00 | 2 | GO:0061713 | BP | anterior neural tube closure |
| 253 | lightyellow | 171 | 9.6e-04 | 1.00 | 15 | GO:0042803 | MF | protein homodimerization activity |
| 254 | lightyellow | 171 | 1.4e-03 | 1.00 | 10 | GO:0032147 | BP | activation of protein kinase activity |
| 255 | lightyellow | 171 | 1.7e-03 | 1.00 | 4 | GO:0008023 | CC | transcription elongation factor complex |
| 256 | lightyellow | 171 | 1.7e-03 | 1.00 | 17 | GO:0045859 | BP | regulation of protein kinase activity |
| 257 | lightyellow | 171 | 1.8e-03 | 1.00 | 2 | GO:0097680 | BP | double-strand break repair via classical nonhomologous end joining |
| 258 | lightyellow | 171 | 1.9e-03 | 1.00 | 55 | GO:0006464 | BP | cellular protein modification process |
| 259 | lightyellow | 171 | 1.9e-03 | 1.00 | 55 | GO:0036211 | BP | protein modification process |
| 260 | lightyellow | 171 | 2.0e-03 | 1.00 | 3 | GO:0004709 | MF | MAP kinase kinase kinase activity |
| 261 | magenta | 361 | 3.1e-04 | 1.00 | 4 | GO:1900225 | BP | regulation of NLRP3 inflammasome complex assembly |
| 262 | magenta | 361 | 4.3e-04 | 1.00 | 4 | GO:0044546 | BP | NLRP3 inflammasome complex assembly |
| 263 | magenta | 361 | 5.4e-04 | 1.00 | 11 | GO:0050907 | BP | detection of chemical stimulus involved in sensory perception |
| 264 | magenta | 361 | 5.6e-04 | 1.00 | 12 | GO:0009593 | BP | detection of chemical stimulus |
| 265 | magenta | 361 | 8.7e-04 | 1.00 | 2 | GO:0035927 | BP | RNA import into mitochondrion |
| 266 | magenta | 361 | 8.7e-04 | 1.00 | 2 | GO:0035928 | BP | rRNA import into mitochondrion |
| 267 | magenta | 361 | 8.7e-04 | 1.00 | 2 | GO:0003828 | MF | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity |
| 268 | magenta | 361 | 8.7e-04 | 1.00 | 2 | GO:0033677 | MF | DNA/RNA helicase activity |
| 269 | magenta | 361 | 1.1e-03 | 1.00 | 12 | GO:0050906 | BP | detection of stimulus involved in sensory perception |
| 270 | magenta | 361 | 1.1e-03 | 1.00 | 10 | GO:0007608 | BP | sensory perception of smell |
| 271 | mediumpurple3 | 55 | 1.2e-03 | 1.00 | 2 | GO:0000463 | BP | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| 272 | mediumpurple3 | 55 | 1.5e-03 | 1.00 | 3 | GO:0051899 | BP | membrane depolarization |
| 273 | mediumpurple3 | 55 | 1.7e-03 | 1.00 | 2 | GO:0005847 | CC | mRNA cleavage and polyadenylation specificity factor complex |
| 274 | mediumpurple3 | 55 | 2.3e-03 | 1.00 | 5 | GO:0007568 | BP | aging |
| 275 | mediumpurple3 | 55 | 2.8e-03 | 1.00 | 2 | GO:0005849 | CC | mRNA cleavage factor complex |
| 276 | mediumpurple3 | 55 | 3.1e-03 | 1.00 | 2 | GO:0035590 | BP | purinergic nucleotide receptor signaling pathway |
| 277 | mediumpurple3 | 55 | 3.5e-03 | 1.00 | 2 | GO:0000470 | BP | maturation of LSU-rRNA |
| 278 | mediumpurple3 | 55 | 4.4e-03 | 1.00 | 1 | GO:0003131 | BP | mesodermal-endodermal cell signaling |
| 279 | mediumpurple3 | 55 | 4.4e-03 | 1.00 | 1 | GO:0006481 | BP | C-terminal protein methylation |
| 280 | mediumpurple3 | 55 | 4.4e-03 | 1.00 | 1 | GO:0006532 | BP | aspartate biosynthetic process |
| 281 | midnightblue | 234 | 3.9e-03 | 1.00 | 3 | GO:0050427 | BP | 3’-phosphoadenosine 5’-phosphosulfate metabolic process |
| 282 | midnightblue | 234 | 5.2e-03 | 1.00 | 2 | GO:0007172 | BP | signal complex assembly |
| 283 | midnightblue | 234 | 5.2e-03 | 1.00 | 2 | GO:0035754 | BP | B cell chemotaxis |
| 284 | midnightblue | 234 | 5.2e-03 | 1.00 | 2 | GO:0060050 | BP | positive regulation of protein glycosylation |
| 285 | midnightblue | 234 | 5.2e-03 | 1.00 | 2 | GO:0004062 | MF | aryl sulfotransferase activity |
| 286 | midnightblue | 234 | 5.2e-03 | 1.00 | 2 | GO:0004298 | MF | threonine-type endopeptidase activity |
| 287 | midnightblue | 234 | 6.2e-03 | 1.00 | 18 | GO:0016773 | MF | phosphotransferase activity, alcohol group as acceptor |
| 288 | midnightblue | 234 | 7.3e-03 | 1.00 | 2 | GO:0035845 | BP | photoreceptor cell outer segment organization |
| 289 | midnightblue | 234 | 7.3e-03 | 1.00 | 2 | GO:1902237 | BP | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
| 290 | midnightblue | 234 | 7.6e-03 | 1.00 | 5 | GO:0007589 | BP | body fluid secretion |
| 291 | orange | 113 | 2.5e-05 | 0.46 | 3 | GO:0106074 | BP | aminoacyl-tRNA metabolism involved in translational fidelity |
| 292 | orange | 113 | 2.5e-05 | 0.46 | 3 | GO:0002161 | MF | aminoacyl-tRNA editing activity |
| 293 | orange | 113 | 8.4e-05 | 1.00 | 3 | GO:0006450 | BP | regulation of translational fidelity |
| 294 | orange | 113 | 2.4e-04 | 1.00 | 2 | GO:0055096 | BP | low-density lipoprotein particle mediated signaling |
| 295 | orange | 113 | 2.4e-04 | 1.00 | 2 | GO:0060956 | BP | endocardial cell differentiation |
| 296 | orange | 113 | 4.9e-04 | 1.00 | 2 | GO:0050957 | BP | equilibrioception |
| 297 | orange | 113 | 6.4e-04 | 1.00 | 3 | GO:0000729 | BP | DNA double-strand break processing |
| 298 | orange | 113 | 1.2e-03 | 1.00 | 2 | GO:0060836 | BP | lymphatic endothelial cell differentiation |
| 299 | orange | 113 | 1.2e-03 | 1.00 | 2 | GO:0048179 | CC | activin receptor complex |
| 300 | orange | 113 | 1.3e-03 | 1.00 | 3 | GO:0050885 | BP | neuromuscular process controlling balance |
| 301 | orangered4 | 56 | 4.6e-04 | 1.00 | 3 | GO:0048066 | BP | developmental pigmentation |
| 302 | orangered4 | 56 | 1.6e-03 | 1.00 | 2 | GO:0048070 | BP | regulation of developmental pigmentation |
| 303 | orangered4 | 56 | 3.9e-03 | 1.00 | 3 | GO:0043473 | BP | pigmentation |
| 304 | orangered4 | 56 | 4.0e-03 | 1.00 | 2 | GO:0050690 | BP | regulation of defense response to virus by virus |
| 305 | orangered4 | 56 | 4.3e-03 | 1.00 | 1 | GO:0006480 | BP | N-terminal protein amino acid methylation |
| 306 | orangered4 | 56 | 4.3e-03 | 1.00 | 1 | GO:0018011 | BP | N-terminal peptidyl-alanine methylation |
| 307 | orangered4 | 56 | 4.3e-03 | 1.00 | 1 | GO:0018012 | BP | N-terminal peptidyl-alanine trimethylation |
| 308 | orangered4 | 56 | 4.3e-03 | 1.00 | 1 | GO:0018013 | BP | N-terminal peptidyl-glycine methylation |
| 309 | orangered4 | 56 | 4.3e-03 | 1.00 | 1 | GO:0018016 | BP | N-terminal peptidyl-proline dimethylation |
| 310 | orangered4 | 56 | 4.3e-03 | 1.00 | 1 | GO:0032023 | BP | trypsinogen activation |
| 311 | paleturquoise | 86 | 1.1e-03 | 1.00 | 3 | GO:0042769 | BP | DNA damage response, detection of DNA damage |
| 312 | paleturquoise | 86 | 1.5e-03 | 1.00 | 2 | GO:0034384 | BP | high-density lipoprotein particle clearance |
| 313 | paleturquoise | 86 | 3.2e-03 | 1.00 | 2 | GO:0008308 | MF | voltage-gated anion channel activity |
| 314 | paleturquoise | 86 | 4.0e-03 | 1.00 | 3 | GO:0002039 | MF | p53 binding |
| 315 | paleturquoise | 86 | 4.8e-03 | 1.00 | 2 | GO:0034364 | CC | high-density lipoprotein particle |
| 316 | paleturquoise | 86 | 5.4e-03 | 1.00 | 2 | GO:0071243 | BP | cellular response to arsenic-containing substance |
| 317 | paleturquoise | 86 | 5.5e-03 | 1.00 | 4 | GO:0019933 | BP | cAMP-mediated signaling |
| 318 | paleturquoise | 86 | 6.6e-03 | 1.00 | 1 | GO:0010902 | BP | positive regulation of very-low-density lipoprotein particle remodeling |
| 319 | paleturquoise | 86 | 6.6e-03 | 1.00 | 1 | GO:0031443 | BP | fast-twitch skeletal muscle fiber contraction |
| 320 | paleturquoise | 86 | 6.6e-03 | 1.00 | 1 | GO:0031448 | BP | positive regulation of fast-twitch skeletal muscle fiber contraction |
| 321 | palevioletred3 | 29 | 3.2e-04 | 1.00 | 2 | GO:0045006 | BP | DNA deamination |
| 322 | palevioletred3 | 29 | 2.5e-03 | 1.00 | 1 | GO:1990467 | CC | NuA3a histone acetyltransferase complex |
| 323 | palevioletred3 | 29 | 2.5e-03 | 1.00 | 1 | GO:1990468 | CC | NuA3b histone acetyltransferase complex |
| 324 | palevioletred3 | 29 | 3.3e-03 | 1.00 | 2 | GO:0046839 | BP | phospholipid dephosphorylation |
| 325 | palevioletred3 | 29 | 4.1e-03 | 1.00 | 2 | GO:0005548 | MF | phospholipid transporter activity |
| 326 | palevioletred3 | 29 | 4.9e-03 | 1.00 | 1 | GO:0051611 | BP | regulation of serotonin uptake |
| 327 | palevioletred3 | 29 | 4.9e-03 | 1.00 | 1 | GO:0051612 | BP | negative regulation of serotonin uptake |
| 328 | palevioletred3 | 29 | 4.9e-03 | 1.00 | 1 | GO:0005846 | CC | nuclear cap binding complex |
| 329 | palevioletred3 | 29 | 4.9e-03 | 1.00 | 1 | GO:0001785 | MF | prostaglandin J receptor activity |
| 330 | palevioletred3 | 29 | 4.9e-03 | 1.00 | 1 | GO:0004956 | MF | prostaglandin D receptor activity |
| 331 | pink | 433 | 5.3e-05 | 0.97 | 4 | GO:0090237 | BP | regulation of arachidonic acid secretion |
| 332 | pink | 433 | 8.5e-04 | 1.00 | 3 | GO:0090238 | BP | positive regulation of arachidonic acid secretion |
| 333 | pink | 433 | 8.5e-04 | 1.00 | 3 | GO:1901339 | BP | regulation of store-operated calcium channel activity |
| 334 | pink | 433 | 1.2e-03 | 1.00 | 4 | GO:0032305 | BP | positive regulation of icosanoid secretion |
| 335 | pink | 433 | 1.4e-03 | 1.00 | 3 | GO:0002638 | BP | negative regulation of immunoglobulin production |
| 336 | pink | 433 | 2.1e-03 | 1.00 | 5 | GO:0033144 | BP | negative regulation of intracellular steroid hormone receptor signaling pathway |
| 337 | pink | 433 | 2.1e-03 | 1.00 | 5 | GO:0045648 | BP | positive regulation of erythrocyte differentiation |
| 338 | pink | 433 | 2.1e-03 | 1.00 | 4 | GO:2000193 | BP | positive regulation of fatty acid transport |
| 339 | pink | 433 | 2.2e-03 | 1.00 | 6 | GO:0051055 | BP | negative regulation of lipid biosynthetic process |
| 340 | pink | 433 | 2.8e-03 | 1.00 | 6 | GO:0010883 | BP | regulation of lipid storage |
| 341 | plum1 | 62 | 1.3e-04 | 1.00 | 3 | GO:0021988 | BP | olfactory lobe development |
| 342 | plum1 | 62 | 2.5e-04 | 1.00 | 2 | GO:0021889 | BP | olfactory bulb interneuron differentiation |
| 343 | plum1 | 62 | 1.0e-03 | 1.00 | 8 | GO:0006281 | BP | DNA repair |
| 344 | plum1 | 62 | 1.2e-03 | 1.00 | 37 | GO:0005634 | CC | nucleus |
| 345 | plum1 | 62 | 1.6e-03 | 1.00 | 2 | GO:0030983 | MF | mismatched DNA binding |
| 346 | plum1 | 62 | 1.7e-03 | 1.00 | 10 | GO:0006259 | BP | DNA metabolic process |
| 347 | plum1 | 62 | 2.3e-03 | 1.00 | 21 | GO:0003676 | MF | nucleic acid binding |
| 348 | plum1 | 62 | 2.7e-03 | 1.00 | 34 | GO:0019222 | BP | regulation of metabolic process |
| 349 | plum1 | 62 | 2.9e-03 | 1.00 | 3 | GO:0035064 | MF | methylated histone binding |
| 350 | plum1 | 62 | 3.1e-03 | 1.00 | 4 | GO:0140030 | MF | modification-dependent protein binding |
| 351 | plum2 | 32 | 9.5e-04 | 1.00 | 2 | GO:0005520 | MF | insulin-like growth factor binding |
| 352 | plum2 | 32 | 1.2e-03 | 1.00 | 2 | GO:0007398 | BP | ectoderm development |
| 353 | plum2 | 32 | 2.6e-03 | 1.00 | 2 | GO:0038083 | BP | peptidyl-tyrosine autophosphorylation |
| 354 | plum2 | 32 | 2.7e-03 | 1.00 | 1 | GO:0002626 | BP | negative regulation of T cell antigen processing and presentation |
| 355 | plum2 | 32 | 2.7e-03 | 1.00 | 1 | GO:0010106 | BP | cellular response to iron ion starvation |
| 356 | plum2 | 32 | 2.7e-03 | 1.00 | 1 | GO:1904283 | BP | negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I |
| 357 | plum2 | 32 | 2.7e-03 | 1.00 | 1 | GO:1904434 | BP | positive regulation of ferrous iron binding |
| 358 | plum2 | 32 | 2.7e-03 | 1.00 | 1 | GO:1904437 | BP | positive regulation of transferrin receptor binding |
| 359 | plum2 | 32 | 2.7e-03 | 1.00 | 1 | GO:1990641 | BP | response to iron ion starvation |
| 360 | plum2 | 32 | 2.7e-03 | 1.00 | 1 | GO:0034676 | CC | integrin alpha6-beta4 complex |
| 361 | purple | 362 | 8.5e-04 | 1.00 | 4 | GO:0071218 | BP | cellular response to misfolded protein |
| 362 | purple | 362 | 9.1e-04 | 1.00 | 11 | GO:0032874 | BP | positive regulation of stress-activated MAPK cascade |
| 363 | purple | 362 | 9.8e-04 | 1.00 | 11 | GO:0070304 | BP | positive regulation of stress-activated protein kinase signaling cascade |
| 364 | purple | 362 | 1.1e-03 | 1.00 | 4 | GO:0051788 | BP | response to misfolded protein |
| 365 | purple | 362 | 1.4e-03 | 1.00 | 3 | GO:0070142 | BP | synaptic vesicle budding |
| 366 | purple | 362 | 1.7e-03 | 1.00 | 6 | GO:0031102 | BP | neuron projection regeneration |
| 367 | purple | 362 | 2.0e-03 | 1.00 | 3 | GO:0033089 | BP | positive regulation of T cell differentiation in thymus |
| 368 | purple | 362 | 2.0e-03 | 1.00 | 3 | GO:0044327 | CC | dendritic spine head |
| 369 | purple | 362 | 2.7e-03 | 1.00 | 2 | GO:0010916 | BP | negative regulation of very-low-density lipoprotein particle clearance |
| 370 | purple | 362 | 2.7e-03 | 1.00 | 2 | GO:0097026 | BP | dendritic cell dendrite assembly |
| 371 | red | 639 | 1.5e-04 | 1.00 | 3 | GO:0032765 | BP | positive regulation of mast cell cytokine production |
| 372 | red | 639 | 7.0e-04 | 1.00 | 11 | GO:0001510 | BP | RNA methylation |
| 373 | red | 639 | 8.1e-04 | 1.00 | 10 | GO:0008173 | MF | RNA methyltransferase activity |
| 374 | red | 639 | 2.6e-03 | 1.00 | 3 | GO:0032762 | BP | mast cell cytokine production |
| 375 | red | 639 | 2.8e-03 | 1.00 | 2 | GO:0010724 | BP | regulation of definitive erythrocyte differentiation |
| 376 | red | 639 | 2.8e-03 | 1.00 | 2 | GO:0035600 | BP | tRNA methylthiolation |
| 377 | red | 639 | 2.8e-03 | 1.00 | 2 | GO:1900168 | BP | positive regulation of glial cell-derived neurotrophic factor secretion |
| 378 | red | 639 | 2.8e-03 | 1.00 | 2 | GO:0005093 | MF | Rab GDP-dissociation inhibitor activity |
| 379 | red | 639 | 2.8e-03 | 1.00 | 2 | GO:0035596 | MF | methylthiotransferase activity |
| 380 | red | 639 | 3.0e-03 | 1.00 | 15 | GO:0009451 | BP | RNA modification |
| 381 | royalblue | 169 | 7.4e-05 | 1.00 | 4 | GO:0034315 | BP | regulation of Arp2/3 complex-mediated actin nucleation |
| 382 | royalblue | 169 | 1.7e-04 | 1.00 | 5 | GO:0051293 | BP | establishment of spindle localization |
| 383 | royalblue | 169 | 1.9e-04 | 1.00 | 2 | GO:0097037 | BP | heme export |
| 384 | royalblue | 169 | 2.4e-04 | 1.00 | 5 | GO:0051653 | BP | spindle localization |
| 385 | royalblue | 169 | 2.5e-04 | 1.00 | 7 | GO:0046887 | BP | positive regulation of hormone secretion |
| 386 | royalblue | 169 | 3.0e-04 | 1.00 | 6 | GO:0090277 | BP | positive regulation of peptide hormone secretion |
| 387 | royalblue | 169 | 3.6e-04 | 1.00 | 4 | GO:0051125 | BP | regulation of actin nucleation |
| 388 | royalblue | 169 | 4.0e-04 | 1.00 | 3 | GO:0071933 | MF | Arp2/3 complex binding |
| 389 | royalblue | 169 | 5.6e-04 | 1.00 | 4 | GO:0034314 | BP | Arp2/3 complex-mediated actin nucleation |
| 390 | royalblue | 169 | 5.7e-04 | 1.00 | 2 | GO:0071672 | BP | negative regulation of smooth muscle cell chemotaxis |
| 391 | saddlebrown | 89 | 5.0e-05 | 0.93 | 2 | GO:0090108 | BP | positive regulation of high-density lipoprotein particle assembly |
| 392 | saddlebrown | 89 | 6.6e-05 | 1.00 | 5 | GO:0030301 | BP | cholesterol transport |
| 393 | saddlebrown | 89 | 1.2e-04 | 1.00 | 4 | GO:0055008 | BP | cardiac muscle tissue morphogenesis |
| 394 | saddlebrown | 89 | 1.2e-04 | 1.00 | 3 | GO:0003209 | BP | cardiac atrium morphogenesis |
| 395 | saddlebrown | 89 | 1.3e-04 | 1.00 | 4 | GO:0010718 | BP | positive regulation of epithelial to mesenchymal transition |
| 396 | saddlebrown | 89 | 1.5e-04 | 1.00 | 3 | GO:0006907 | BP | pinocytosis |
| 397 | saddlebrown | 89 | 1.5e-04 | 1.00 | 2 | GO:0090107 | BP | regulation of high-density lipoprotein particle assembly |
| 398 | saddlebrown | 89 | 1.5e-04 | 1.00 | 2 | GO:0099039 | BP | sphingolipid translocation |
| 399 | saddlebrown | 89 | 1.6e-04 | 1.00 | 5 | GO:0015918 | BP | sterol transport |
| 400 | saddlebrown | 89 | 1.8e-04 | 1.00 | 4 | GO:0060415 | BP | muscle tissue morphogenesis |
| 401 | salmon | 240 | 1.3e-04 | 1.00 | 5 | GO:0031572 | BP | G2 DNA damage checkpoint |
| 402 | salmon | 240 | 3.5e-04 | 1.00 | 4 | GO:0007095 | BP | mitotic G2 DNA damage checkpoint |
| 403 | salmon | 240 | 3.8e-04 | 1.00 | 2 | GO:0010706 | BP | ganglioside biosynthetic process via lactosylceramide |
| 404 | salmon | 240 | 7.1e-04 | 1.00 | 8 | GO:0008194 | MF | UDP-glycosyltransferase activity |
| 405 | salmon | 240 | 9.4e-04 | 1.00 | 4 | GO:0022616 | BP | DNA strand elongation |
| 406 | salmon | 240 | 1.1e-03 | 1.00 | 13 | GO:0009101 | BP | glycoprotein biosynthetic process |
| 407 | salmon | 240 | 1.1e-03 | 1.00 | 2 | GO:0001807 | BP | regulation of type IV hypersensitivity |
| 408 | salmon | 240 | 1.1e-03 | 1.00 | 2 | GO:0006272 | BP | leading strand elongation |
| 409 | salmon | 240 | 1.1e-03 | 1.00 | 2 | GO:0008489 | MF | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity |
| 410 | salmon | 240 | 1.3e-03 | 1.00 | 4 | GO:0044818 | BP | mitotic G2/M transition checkpoint |
| 411 | salmon4 | 33 | 2.5e-03 | 1.00 | 3 | GO:0042177 | BP | negative regulation of protein catabolic process |
| 412 | salmon4 | 33 | 2.8e-03 | 1.00 | 1 | GO:0003199 | BP | endocardial cushion to mesenchymal transition involved in heart valve formation |
| 413 | salmon4 | 33 | 2.8e-03 | 1.00 | 1 | GO:0042351 | BP | ‘de novo’ GDP-L-fucose biosynthetic process |
| 414 | salmon4 | 33 | 2.8e-03 | 1.00 | 1 | GO:1901919 | BP | positive regulation of exoribonuclease activity |
| 415 | salmon4 | 33 | 2.8e-03 | 1.00 | 1 | GO:1905143 | BP | eukaryotic translation initiation factor 2 complex assembly |
| 416 | salmon4 | 33 | 2.8e-03 | 1.00 | 1 | GO:0071540 | CC | eukaryotic translation initiation factor 3 complex, eIF3e |
| 417 | salmon4 | 33 | 2.8e-03 | 1.00 | 1 | GO:0004607 | MF | phosphatidylcholine-sterol O-acyltransferase activity |
| 418 | salmon4 | 33 | 2.8e-03 | 1.00 | 1 | GO:0008446 | MF | GDP-mannose 4,6-dehydratase activity |
| 419 | salmon4 | 33 | 4.4e-03 | 1.00 | 3 | GO:0043409 | BP | negative regulation of MAPK cascade |
| 420 | salmon4 | 33 | 5.6e-03 | 1.00 | 1 | GO:0000448 | BP | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| 421 | sienna3 | 64 | 4.1e-04 | 1.00 | 2 | GO:2000373 | BP | positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity |
| 422 | sienna3 | 64 | 5.7e-04 | 1.00 | 2 | GO:0036006 | BP | cellular response to macrophage colony-stimulating factor stimulus |
| 423 | sienna3 | 64 | 1.4e-03 | 1.00 | 4 | GO:0032946 | BP | positive regulation of mononuclear cell proliferation |
| 424 | sienna3 | 64 | 1.6e-03 | 1.00 | 3 | GO:0042698 | BP | ovulation cycle |
| 425 | sienna3 | 64 | 1.7e-03 | 1.00 | 4 | GO:0070665 | BP | positive regulation of leukocyte proliferation |
| 426 | sienna3 | 64 | 2.0e-03 | 1.00 | 3 | GO:0051057 | BP | positive regulation of small GTPase mediated signal transduction |
| 427 | sienna3 | 64 | 2.1e-03 | 1.00 | 2 | GO:0032211 | BP | negative regulation of telomere maintenance via telomerase |
| 428 | sienna3 | 64 | 2.5e-03 | 1.00 | 7 | GO:0007005 | BP | mitochondrion organization |
| 429 | sienna3 | 64 | 2.7e-03 | 1.00 | 3 | GO:0034103 | BP | regulation of tissue remodeling |
| 430 | sienna3 | 64 | 3.9e-03 | 1.00 | 6 | GO:0045785 | BP | positive regulation of cell adhesion |
| 431 | skyblue | 96 | 2.1e-04 | 1.00 | 3 | GO:0021801 | BP | cerebral cortex radial glia guided migration |
| 432 | skyblue | 96 | 2.5e-04 | 1.00 | 5 | GO:0030175 | CC | filopodium |
| 433 | skyblue | 96 | 3.7e-04 | 1.00 | 3 | GO:0021895 | BP | cerebral cortex neuron differentiation |
| 434 | skyblue | 96 | 5.9e-04 | 1.00 | 3 | GO:0021799 | BP | cerebral cortex radially oriented cell migration |
| 435 | skyblue | 96 | 6.2e-04 | 1.00 | 2 | GO:2000138 | BP | positive regulation of cell proliferation involved in heart morphogenesis |
| 436 | skyblue | 96 | 7.8e-04 | 1.00 | 3 | GO:0010656 | BP | negative regulation of muscle cell apoptotic process |
| 437 | skyblue | 96 | 7.8e-04 | 1.00 | 3 | GO:0042491 | BP | inner ear auditory receptor cell differentiation |
| 438 | skyblue | 96 | 8.3e-04 | 1.00 | 4 | GO:0035019 | BP | somatic stem cell population maintenance |
| 439 | skyblue | 96 | 9.3e-04 | 1.00 | 2 | GO:0036302 | BP | atrioventricular canal development |
| 440 | skyblue | 96 | 1.1e-03 | 1.00 | 3 | GO:0021795 | BP | cerebral cortex cell migration |
| 441 | skyblue3 | 60 | 2.4e-05 | 0.44 | 2 | GO:0003419 | BP | growth plate cartilage chondrocyte proliferation |
| 442 | skyblue3 | 60 | 2.4e-05 | 0.44 | 2 | GO:0003420 | BP | regulation of growth plate cartilage chondrocyte proliferation |
| 443 | skyblue3 | 60 | 1.1e-03 | 1.00 | 9 | GO:0006325 | BP | chromatin organization |
| 444 | skyblue3 | 60 | 1.1e-03 | 1.00 | 3 | GO:0061035 | BP | regulation of cartilage development |
| 445 | skyblue3 | 60 | 1.5e-03 | 1.00 | 2 | GO:0003417 | BP | growth plate cartilage development |
| 446 | skyblue3 | 60 | 1.6e-03 | 1.00 | 5 | GO:2000027 | BP | regulation of animal organ morphogenesis |
| 447 | skyblue3 | 60 | 1.8e-03 | 1.00 | 2 | GO:1903010 | BP | regulation of bone development |
| 448 | skyblue3 | 60 | 2.0e-03 | 1.00 | 3 | GO:0051279 | BP | regulation of release of sequestered calcium ion into cytosol |
| 449 | skyblue3 | 60 | 2.7e-03 | 1.00 | 2 | GO:0007628 | BP | adult walking behavior |
| 450 | skyblue3 | 60 | 2.8e-03 | 1.00 | 11 | GO:0051276 | BP | chromosome organization |
| 451 | steelblue | 93 | 1.2e-03 | 1.00 | 2 | GO:0045348 | BP | positive regulation of MHC class II biosynthetic process |
| 452 | steelblue | 93 | 1.6e-03 | 1.00 | 5 | GO:0035148 | BP | tube formation |
| 453 | steelblue | 93 | 1.6e-03 | 1.00 | 3 | GO:0043370 | BP | regulation of CD4-positive, alpha-beta T cell differentiation |
| 454 | steelblue | 93 | 2.5e-03 | 1.00 | 2 | GO:0032426 | CC | stereocilium tip |
| 455 | steelblue | 93 | 3.0e-03 | 1.00 | 2 | GO:0045342 | BP | MHC class II biosynthetic process |
| 456 | steelblue | 93 | 3.0e-03 | 1.00 | 2 | GO:0035497 | MF | cAMP response element binding |
| 457 | steelblue | 93 | 3.9e-03 | 1.00 | 6 | GO:0061629 | MF | RNA polymerase II-specific DNA-binding transcription factor binding |
| 458 | steelblue | 93 | 3.9e-03 | 1.00 | 3 | GO:2000514 | BP | regulation of CD4-positive, alpha-beta T cell activation |
| 459 | steelblue | 93 | 4.2e-03 | 1.00 | 2 | GO:0045624 | BP | positive regulation of T-helper cell differentiation |
| 460 | steelblue | 93 | 4.2e-03 | 1.00 | 2 | GO:0055012 | BP | ventricular cardiac muscle cell differentiation |
| 461 | tan | 291 | 5.8e-04 | 1.00 | 2 | GO:0006226 | BP | dUMP biosynthetic process |
| 462 | tan | 291 | 5.8e-04 | 1.00 | 2 | GO:0052642 | MF | lysophosphatidic acid phosphatase activity |
| 463 | tan | 291 | 6.0e-04 | 1.00 | 6 | GO:0071300 | BP | cellular response to retinoic acid |
| 464 | tan | 291 | 7.1e-04 | 1.00 | 3 | GO:2001054 | BP | negative regulation of mesenchymal cell apoptotic process |
| 465 | tan | 291 | 7.2e-04 | 1.00 | 52 | GO:0042886 | BP | amide transport |
| 466 | tan | 291 | 9.6e-04 | 1.00 | 50 | GO:0015031 | BP | protein transport |
| 467 | tan | 291 | 9.7e-04 | 1.00 | 57 | GO:0071705 | BP | nitrogen compound transport |
| 468 | tan | 291 | 1.4e-03 | 1.00 | 5 | GO:2001239 | BP | regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| 469 | tan | 291 | 1.4e-03 | 1.00 | 33 | GO:0006886 | BP | intracellular protein transport |
| 470 | tan | 291 | 1.5e-03 | 1.00 | 3 | GO:0097152 | BP | mesenchymal cell apoptotic process |
| 471 | thistle1 | 31 | 1.5e-03 | 1.00 | 4 | GO:0005996 | BP | monosaccharide metabolic process |
| 472 | thistle1 | 31 | 1.5e-03 | 1.00 | 4 | GO:0044262 | BP | cellular carbohydrate metabolic process |
| 473 | thistle1 | 31 | 2.5e-03 | 1.00 | 1 | GO:0005956 | CC | protein kinase CK2 complex |
| 474 | thistle1 | 31 | 2.5e-03 | 1.00 | 1 | GO:0038037 | CC | G protein-coupled receptor dimeric complex |
| 475 | thistle1 | 31 | 2.5e-03 | 1.00 | 1 | GO:0038039 | CC | G protein-coupled receptor heterodimeric complex |
| 476 | thistle1 | 31 | 2.5e-03 | 1.00 | 1 | GO:0004616 | MF | phosphogluconate dehydrogenase (decarboxylating) activity |
| 477 | thistle1 | 31 | 2.5e-03 | 1.00 | 1 | GO:0004965 | MF | G protein-coupled GABA receptor activity |
| 478 | thistle1 | 31 | 2.5e-03 | 1.00 | 1 | GO:0047933 | MF | glucose-1,6-bisphosphate synthase activity |
| 479 | thistle1 | 31 | 2.8e-03 | 1.00 | 2 | GO:0044275 | BP | cellular carbohydrate catabolic process |
| 480 | thistle1 | 31 | 4.9e-03 | 1.00 | 1 | GO:0042309 | BP | homoiothermy |
| 481 | thistle2 | 37 | 7.2e-04 | 1.00 | 2 | GO:1990404 | MF | protein ADP-ribosylase activity |
| 482 | thistle2 | 37 | 8.3e-04 | 1.00 | 2 | GO:0060391 | BP | positive regulation of SMAD protein signal transduction |
| 483 | thistle2 | 37 | 1.2e-03 | 1.00 | 2 | GO:0003950 | MF | NAD+ ADP-ribosyltransferase activity |
| 484 | thistle2 | 37 | 1.6e-03 | 1.00 | 2 | GO:0060390 | BP | regulation of SMAD protein signal transduction |
| 485 | thistle2 | 37 | 2.3e-03 | 1.00 | 4 | GO:0016757 | MF | transferase activity, transferring glycosyl groups |
| 486 | thistle2 | 37 | 2.5e-03 | 1.00 | 2 | GO:0006471 | BP | protein ADP-ribosylation |
| 487 | thistle2 | 37 | 2.5e-03 | 1.00 | 2 | GO:2000781 | BP | positive regulation of double-strand break repair |
| 488 | thistle2 | 37 | 2.9e-03 | 1.00 | 1 | GO:0018424 | BP | peptidyl-glutamic acid poly-ADP-ribosylation |
| 489 | thistle2 | 37 | 2.9e-03 | 1.00 | 1 | GO:1902173 | BP | negative regulation of keratinocyte apoptotic process |
| 490 | thistle2 | 37 | 2.9e-03 | 1.00 | 1 | GO:1904762 | BP | positive regulation of myofibroblast differentiation |
| 491 | turquoise | 1758 | 4.4e-04 | 1.00 | 4 | GO:0015705 | BP | iodide transport |
| 492 | turquoise | 1758 | 1.0e-03 | 1.00 | 14 | GO:1905515 | BP | non-motile cilium assembly |
| 493 | turquoise | 1758 | 1.0e-03 | 1.00 | 7 | GO:0071850 | BP | mitotic cell cycle arrest |
| 494 | turquoise | 1758 | 1.0e-03 | 1.00 | 5 | GO:0051601 | BP | exocyst localization |
| 495 | turquoise | 1758 | 1.0e-03 | 1.00 | 5 | GO:0071494 | BP | cellular response to UV-C |
| 496 | turquoise | 1758 | 1.2e-03 | 1.00 | 6 | GO:0031080 | CC | nuclear pore outer ring |
| 497 | turquoise | 1758 | 1.2e-03 | 1.00 | 11 | GO:0031491 | MF | nucleosome binding |
| 498 | turquoise | 1758 | 1.3e-03 | 1.00 | 16 | GO:0031122 | BP | cytoplasmic microtubule organization |
| 499 | turquoise | 1758 | 1.4e-03 | 1.00 | 8 | GO:0034629 | BP | cellular protein-containing complex localization |
| 500 | turquoise | 1758 | 1.4e-03 | 1.00 | 85 | GO:0000226 | BP | microtubule cytoskeleton organization |
| 501 | violet | 76 | 5.6e-04 | 1.00 | 2 | GO:0010793 | BP | regulation of mRNA export from nucleus |
| 502 | violet | 76 | 1.3e-03 | 1.00 | 2 | GO:0018455 | MF | alcohol dehydrogenase [NAD(P)+] activity |
| 503 | violet | 76 | 1.9e-03 | 1.00 | 3 | GO:0002920 | BP | regulation of humoral immune response |
| 504 | violet | 76 | 2.4e-03 | 1.00 | 2 | GO:0035269 | BP | protein O-linked mannosylation |
| 505 | violet | 76 | 2.5e-03 | 1.00 | 3 | GO:0016529 | CC | sarcoplasmic reticulum |
| 506 | violet | 76 | 2.8e-03 | 1.00 | 2 | GO:0046831 | BP | regulation of RNA export from nucleus |
| 507 | violet | 76 | 3.8e-03 | 1.00 | 2 | GO:0042026 | BP | protein refolding |
| 508 | violet | 76 | 3.9e-03 | 1.00 | 3 | GO:0016528 | CC | sarcoplasm |
| 509 | violet | 76 | 4.3e-03 | 1.00 | 2 | GO:0035268 | BP | protein mannosylation |
| 510 | violet | 76 | 5.5e-03 | 1.00 | 2 | GO:0003416 | BP | endochondral bone growth |
| 511 | white | 100 | 1.8e-04 | 1.00 | 3 | GO:0033617 | BP | mitochondrial cytochrome c oxidase assembly |
| 512 | white | 100 | 2.2e-04 | 1.00 | 3 | GO:0008535 | BP | respiratory chain complex IV assembly |
| 513 | white | 100 | 3.0e-04 | 1.00 | 5 | GO:0033108 | BP | mitochondrial respiratory chain complex assembly |
| 514 | white | 100 | 3.9e-04 | 1.00 | 2 | GO:0015722 | BP | canalicular bile acid transport |
| 515 | white | 100 | 5.4e-04 | 1.00 | 3 | GO:0050832 | BP | defense response to fungus |
| 516 | white | 100 | 9.4e-04 | 1.00 | 3 | GO:0017004 | BP | cytochrome complex assembly |
| 517 | white | 100 | 9.7e-04 | 1.00 | 2 | GO:0032621 | BP | interleukin-18 production |
| 518 | white | 100 | 1.7e-03 | 1.00 | 3 | GO:0009620 | BP | response to fungus |
| 519 | white | 100 | 2.3e-03 | 1.00 | 2 | GO:0005095 | MF | GTPase inhibitor activity |
| 520 | white | 100 | 2.8e-03 | 1.00 | 2 | GO:1900017 | BP | positive regulation of cytokine production involved in inflammatory response |
| 521 | yellow | 832 | 2.1e-04 | 1.00 | 17 | GO:0009566 | BP | fertilization |
| 522 | yellow | 832 | 2.3e-04 | 1.00 | 13 | GO:0001669 | CC | acrosomal vesicle |
| 523 | yellow | 832 | 2.7e-04 | 1.00 | 5 | GO:0060442 | BP | branching involved in prostate gland morphogenesis |
| 524 | yellow | 832 | 2.9e-04 | 1.00 | 4 | GO:0050543 | MF | icosatetraenoic acid binding |
| 525 | yellow | 832 | 3.2e-04 | 1.00 | 3 | GO:0061484 | BP | hematopoietic stem cell homeostasis |
| 526 | yellow | 832 | 7.7e-04 | 1.00 | 5 | GO:0036041 | MF | long-chain fatty acid binding |
| 527 | yellow | 832 | 8.3e-04 | 1.00 | 7 | GO:0032965 | BP | regulation of collagen biosynthetic process |
| 528 | yellow | 832 | 1.2e-03 | 1.00 | 5 | GO:0010839 | BP | negative regulation of keratinocyte proliferation |
| 529 | yellow | 832 | 1.2e-03 | 1.00 | 3 | GO:0035502 | BP | metanephric part of ureteric bud development |
| 530 | yellow | 832 | 1.2e-03 | 1.00 | 3 | GO:0060481 | BP | lobar bronchus epithelium development |
| 531 | yellowgreen | 63 | 2.0e-03 | 1.00 | 6 | GO:0010038 | BP | response to metal ion |
| 532 | yellowgreen | 63 | 2.1e-03 | 1.00 | 8 | GO:0000323 | CC | lytic vacuole |
| 533 | yellowgreen | 63 | 2.1e-03 | 1.00 | 8 | GO:0005764 | CC | lysosome |
| 534 | yellowgreen | 63 | 2.2e-03 | 1.00 | 3 | GO:0046686 | BP | response to cadmium ion |
| 535 | yellowgreen | 63 | 2.7e-03 | 1.00 | 2 | GO:0032366 | BP | intracellular sterol transport |
| 536 | yellowgreen | 63 | 2.7e-03 | 1.00 | 2 | GO:0032367 | BP | intracellular cholesterol transport |
| 537 | yellowgreen | 63 | 3.0e-03 | 1.00 | 2 | GO:0032743 | BP | positive regulation of interleukin-2 production |
| 538 | yellowgreen | 63 | 3.0e-03 | 1.00 | 2 | GO:0071404 | BP | cellular response to low-density lipoprotein particle stimulus |
| 539 | yellowgreen | 63 | 3.4e-03 | 1.00 | 2 | GO:0043372 | BP | positive regulation of CD4-positive, alpha-beta T cell differentiation |
| 540 | yellowgreen | 63 | 4.3e-03 | 1.00 | 2 | GO:0034383 | BP | low-density lipoprotein particle clearance |
Xarxa cytoscape
Factors de transcripció tots els mòduls associats
Factors de transcripció mòduls per separat
resultsSubset_magenta.csv
| X | logo | geneSet | motif | NES | AUC | TF_highConf | TF_lowConf | nEnrGenes | rankAtMax | enrichedGenes |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 |  |
geneSet | flyfactorsurvey__CG9437_SANGER_5_FBgn0034599 | 3.99 | 0.0655 | 51 | 1089 | APBB2;C1orf116;C2orf27A;CBLB;CKMT2;CLCN3;CRADD;CRHBP;CSNK1G2;CTBP2;DDIT4;DDX17;DOC2B;EDA;EDAR;EFNA1;FAM120B;FAM46A;FNDC3A;GCNT1;HDX;IER5;LHFP;LRIG1;MAPK8IP3;MAT2A;MEIS2;NPAS2;NR4A3;OSBPL1A;PALLD;PCDH9;PDXK;PER2;PICALM;POLH;PRRX1;RNMT;SERPINE1;SGMS1;SNRK;SYT11;TIAM1;TMEM2;TSC22D1;VPS13A;WLS;WRB;ZC3H12D;ZNF131;ZNF835 | ||
| 2 |  |
geneSet | tiffin__TIFDMEM0000105 | 3.97 | 0.0654 | 82 | 1972 | APBB2;ARFGEF1;ASB9;ATP2B4;BEST3;BICC1;BIRC3;C1orf116;C2orf27A;CADPS2;CRHBP;CSNK1G2;CTBP2;DNAJC5B;DOC2B;DUSP14;EDA;EDAR;EFNB1;EHF;EIF4A2;EXT1;FAM120B;FAM46A;FNDC3A;GCNT1;GDA;GEMIN8;GPC3;GPC4;GPR137B;GPR158;HDX;HIVEP2;HOXB3;IGFBP7;IL13RA1;IRF1;ITGA2;ITSN2;KIAA1919;LHFP;MEIS2;MKX;MRAP2;MXD1;NR4A3;NUFIP2;OLIG2;PALLD;PCDH8;PCGF2;PDE11A;PDIK1L;PDXDC2P;PLA2G16;PLCB4;RALGAPA2;RASAL2;RGS2;RNF19A;SAMHD1;SEL1L3;SERPINB5;SGMS1;SIK1;SLC39A10;SLC7A8;SLK;SMAD1;SPTLC1;STK10;TGFB3;TMEM2;TMEM50B;UBR2;USP19;VPS13C;YPEL5;YWHAG;ZC3H12D;ZNF618 | ||
| 3 |  |
geneSet | transfac_public__M00483 | 3.96 | 0.0653 | ATF6 (directAnnotation). | ATF6B; CREB3; CREB3L1; CREB3L4 (inferredBy_MotifSimilarity). CREB3L2 (inferredBy_MotifSimilarity_n_Orthology). | 38 | 726 | ARHGAP17;C2orf27A;CKMT2;CLCN3;CLP1;CNTN6;CSNK1G2;DACT1;DDX17;EFNB1;EGR3;EHF;GCNT1;GEMIN8;GK;HDDC2;HDX;HIVEP2;HOXB3;ITGA2;KDM6A;LRRC32;MAP7D1;MORF4L2;NR4A3;PALLD;PRSS22;PTPRM;RNF19A;SCFD1;SEL1L3;SFRP4;SGMS1;SLC39A10;SYT11;TM9SF3;USP8;ZNF595 |
| 4 |  |
geneSet | cisbp__M4718 | 3.91 | 0.0650 | 44 | 909 | APBB2;ATP2B4;BIRC3;C2orf27A;CBLB;CLCN3;CTBP2;DCDC1;DLEU7;DNAJC5B;EGR3;EHF;FAM46A;FBXO32;FGD4;FNDC3A;GCNT1;GPC3;GPR158;HIVEP2;LPGAT1;MEIS2;NR4A3;NUFIP2;PALLD;PANX1;PDE11A;PKN2;PLCB4;PRKCH;PRKD2;RASGEF1B;SEL1L3;SGMS1;SLC39A10;SLC7A8;SLK;SMAD1;SPTLC1;SUPT5H;TM9SF3;TMEM2;TSC22D1;VPS13C | ||
| 5 |  |
geneSet | cisbp__M2960 | 3.76 | 0.0638 | NR2F2 (directAnnotation). | NR1H4; RARA (inferredBy_MotifSimilarity). | 34 | 657 | ADM;ALOX5;ARHGAP17;C1orf116;CHDH;CLCN3;CNIH3;CTBP2;DACT1;DNAJC5B;DOC2B;DUSP14;EDAR;EFNB1;EHF;EXT1;GCNT1;IRF2;LHFP;LRIG1;MAP7D1;MAPK10;NPAS2;PCGF2;PRDM14;PRPF39;SAMHD1;SEL1L3;SGMS1;SLC7A8;SPACA3;SUPT5H;SYT11;ZNF618 |
| 6 |  |
geneSet | cisbp__M2978 | 3.73 | 0.0636 | ATF6 (directAnnotation). | ATF6B; CREB3; CREB3L1; CREB3L4 (inferredBy_MotifSimilarity). CREB3L2 (inferredBy_MotifSimilarity_n_Orthology). | 36 | 694 | APBB2;ARHGAP17;C2orf27A;CKMT2;CLCN3;CLP1;CNTN6;CSNK1G2;DDX17;EFNB1;EHF;FNDC3A;GCNT1;GK;HDDC2;HDX;HIVEP2;HOXB3;ITGA2;KDM6A;LRRC32;MORF4L2;NAMPT;NDUFA10;PALLD;PTPRM;RNF19A;SCFD1;SEL1L3;SFRP4;SGMS1;SLC39A10;SYT11;TM9SF3;WSB1;ZNF595 |
| 7 |  |
geneSet | cisbp__M4886 | 3.72 | 0.0635 | 34 | 625 | APBB2;C2orf27A;CKMT2;CLCN3;CRADD;CRHBP;CTBP2;DDIT4;DDX17;EDA;FAM46A;FNDC3A;LRIG1;MAT2A;MEIS2;NPAS2;OSBPL1A;PALLD;PCDH9;PDXK;PER2;PICALM;POLH;PRRX1;RNMT;SERPINE1;SGMS1;SYT11;TSC22D1;VPS13A;WLS;WRB;ZNF131;ZNF835 | ||
| 8 |  |
geneSet | cisbp__M4095 | 3.69 | 0.0633 | 39 | 784 | APBB2;BICC1;C2orf27A;CLCN3;CTBP2;DACT1;DDX17;EXT1;FNDC3A;GCNT1;GPC4;HDX;HIVEP2;HOXB3;IGFBP7;ITSN2;KDM6A;MAP7D3;MAPK10;MORF4L2;NAMPT;OLIG2;PALLD;PCDH9;PER2;PLCB4;PPM1L;PRDM14;PRRX1;RNF19A;SGMS1;SLC39A10;SMAD1;SUPT5H;TGFBR1;TMEM2;VIM;WLS;ZC3H12D | ||
| 9 |  |
geneSet | cisbp__M0053 | 3.66 | 0.0630 | 51 | 1211 | ACE;APBB2;ASB9;BIRC3;C2orf27A;CD101;CTBP2;CYLD;DNM2;DUSP14;EHF;F11;FAM46A;FNDC3A;GALNT10;GBP2;GCNT1;GIMAP2;GPC3;HBEGF;HDDC2;HDX;HIVEP2;HOXB3;IRF1;ITSN2;KDM4C;KIAA1919;KLHL25;LRRC8C;MAP7D1;MCOLN1;MRAP2;NR4A3;OLIG2;PALLD;PDE11A;PRPF39;PRRX1;RASGEF1B;RGS2;RNF19A;ROR1;SGMS1;SLC7A8;SMAD1;TGFB3;TIAL1;USP53;VANGL1;ZNF131 | ||
| 10 |  |
geneSet | transfac_pro__M07466 | 3.64 | 0.0629 | SIX1 (directAnnotation). | SIX2; SIX4 (inferredBy_MotifSimilarity). | 36 | 673 | ANXA4;ARFGEF1;ATP2B4;C1orf116;C2orf27A;CNIH3;CRHBP;DACT1;DNAJC5B;EFNB1;EHF;EXT1;FBXO32;GALNT10;GCNT1;KDM4C;LHFP;MAP7D1;MYADM;OLIG2;OSBPL1A;PALLD;PLCB4;PRKCH;RAB19;RGS6;RNF19A;ROR1;SGMS1;SIK1;SLC39A10;SLC7A8;TMEM2;TMEM50B;ZC3H12D;ZNF618 |
resultsSubset_plum2.csv
| X | logo | geneSet | motif | NES | AUC | TF_highConf | TF_lowConf | nEnrGenes | rankAtMax | enrichedGenes |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 |  |
geneSet | predrem__nrMotif1518 | 3.92 | 0.0664 | 22 | 275 | APBB2;C1orf116;CTBP2;DACT1;DENND2C;ERBB3;FBXO32;FGD4;GALNT10;HDX;ITGA2;LRIG1;MEIS2;NETO2;NR4A3;NUDT17;PALLD;SGMS1;SLC7A8;TIAL1;TNFRSF21;ZNF618 | ||
| 2 | |
geneSet | flyfactorsurvey__CG9437_SANGER_5_FBgn0034599 | 3.83 | 0.0657 | 39 | 834 | APBB2;C2orf27A;CBLB;CKMT2;CLCN3;CRADD;CRHBP;CTBP2;DDIT4;DDX17;DOC2B;EDA;FAM46A;HDX;IER5;LRIG1;MAPK8IP3;MEIS2;NPAS2;NR4A3;OSBPL1A;PALLD;PCDH9;PDXK;PER2;PICALM;POLH;PRRX1;RNMT;SERPINE1;SGMS1;SNRK;SYT11;TIAM1;VPS13A;WLS;WRB;ZNF131;ZNF835 | ||
| 3 | |
geneSet | cisbp__M4095 | 3.79 | 0.0654 | 50 | 1247 | APBB2;ATP2B4;BICC1;C2orf27A;CADPS2;CLCN3;CTBP2;DACT1;DCDC1;DDX17;EDA;EDAR;EGR3;EXT1;FAM133B;GPC4;HBEGF;HDX;HIVEP2;HOXB3;IGFBP7;ITSN2;KDM6A;LHFP;MAP7D3;MAPK10;MORF4L2;NAMPT;OLIG2;PALLD;PCDH9;PER2;PLCB4;PPM1L;PPP6R1;PRDM14;PRRX1;RGS2;RNF19A;SGMS1;SLC39A10;SMAD1;SUPT5H;TGFBR1;TMEM2;TMEM50B;VIM;WLS;ZC3H12D;ZNF595 | ||
| 4 | |
geneSet | transfac_public__M00483 | 3.73 | 0.0649 | ATF6 (directAnnotation). | ATF6B; CREB3; CREB3L1; CREB3L4 (inferredBy_MotifSimilarity). CREB3L2 (inferredBy_MotifSimilarity_n_Orthology). | 29 | 550 | C2orf27A;CKMT2;CLCN3;CLP1;CNTN6;DDX17;EFNB1;EGR3;EHF;GK;HDDC2;HIVEP2;HOXB3;ITGA2;KDM6A;LRRC32;MORF4L2;NR4A3;PALLD;PTPRM;RNF19A;SCFD1;SEL1L3;SFRP4;SGMS1;SLC39A10;SYT11;TM9SF3;ZNF595 |
| 5 |  |
geneSet | jaspar__MA0369.1 | 3.63 | 0.0641 | BORCS8-MEF2B; MEF2A; MEF2B; MEF2C; MEF2D (inferredBy_Orthology). | 37 | 872 | ARHGEF38;BEST3;C2orf27A;CBLB;CD74;CKMT2;DACT1;DGKD;ERBB3;FBXO32;GPC4;HBEGF;HIVEP2;IL13RA1;IRF1;ITSN2;MEIS2;NPAS2;NR4A3;OLIG2;OPN3;OSBPL1A;PALLD;PICALM;PUS10;RALGAPA2;RAPGEF5;RASAL2;RASGEF1B;RNF19A;SDC4;SEL1L3;SESN2;SGMS1;SLC39A10;SLC7A8;TMEM50B | |
| 6 |  |
geneSet | transfac_public__M00227 | 3.62 | 0.0641 | 38 | 805 | APBB2;BICC1;C2orf27A;CLCN3;CTBP2;DACT1;DDX17;GPC4;HDX;HIVEP2;HOXB3;IGFBP7;ITSN2;KDM6A;MAP7D3;MAPK10;MORF4L2;NAMPT;OLIG2;PALLD;PCDH9;PER2;PLCB4;PRDM14;PRRX1;PTPRM;RGS2;RNF19A;SGMS1;SLC39A10;SMAD1;SUPT5H;TGFBR1;TMEM2;TMEM50B;VIM;WLS;ZC3H12D | ||
| 7 |  |
geneSet | predrem__nrMotif1313 | 3.62 | 0.0640 | 126 | 4235 | ALPK1;APBB2;ARFGEF1;ARHGEF38;ASB9;ASPHD2;ATG2B;ATP2B4;ATXN7L3B;BIRC3;C10orf88;C1orf116;C2orf27A;CADPS2;CASP1;CBLB;CKMT2;CLCN3;CNTN6;CPO;CRADD;CRHBP;CTBP2;CYLD;CYP2C18;DCDC1;DDX17;DGKD;DLEU7;DNAJC5B;DOC2B;EDAR;EHF;EIF4A2;EPS15;FAM46A;FMN1;GALNT1;GDA;GMDS;GPC3;GPC4;GPR158;GPX3;HDX;HIVEP2;IER3;IGFBP7;IL13RA1;IL7;IRF2;ITGA2;ITSN2;KDM4C;KIRREL3;KRT40;LHFP;LPGAT1;LRIG1;MAPK10;MAPK8IP3;MED14;MEIS2;MKX;MORF4L2;MRPS22;NAMPT;NDUFA10;NETO2;NPAS2;NR4A3;NTN4;OSBPL1A;PALLD;PCDH8;PCDH9;PCGF2;PDE11A;PFN2;PKN2;PLA2G16;PLCB4;PRKCH;PROS1;PRPF39;R3HCC1;RAB19;RAPGEF2;RAPGEF5;RASAL2;RASGEF1B;REPIN1;REPS2;RGS6;SCD5;SDK1;SEL1L3;SERPINB5;SGMS1;SLC2A6;SLC39A10;SLC7A8;SMAD1;SNRPN;SRF;STK10;TC2N;TGFB3;TIAL1;TM9SF3;TMEM144;TMEM2;TMEM50B;TMEM60;TNFRSF21;UBE2A;USP53;VANGL1;VIM;WLS;WRB;ZC3H12D;ZFP36;ZNF124;ZNF610;ZNF780B | ||
| 8 | |
geneSet | cisbp__M4718 | 3.61 | 0.0639 | 70 | 1993 | ADAMTS15;ANXA4;APBB2;ASPHD2;ATP2B4;B4GALT4;BICC1;BIRC3;C2orf27A;CBLB;CD101;CLCN3;CNTN6;CTBP2;CYLD;DCDC1;DLEU7;DNAJC5B;EGR3;EHF;FAM46A;FBXO32;FGD4;GPC3;GPR158;HDX;HIVEP2;LHFP;LPGAT1;MAPK10;MEIS2;MKX;MXD1;NPAS2;NPSR1;NR4A3;NUFIP2;OSBPL1A;PALLD;PANX1;PDE11A;PHAX;PKN2;PLCB4;PPM1L;PRKCH;PUS10;QDPR;RAPGEF2;RASGEF1B;RNF19A;SEL1L3;SERPINB8;SGMS1;SLC39A10;SLC7A8;SLK;SMAD1;SPTLC1;SRR;SUPT5H;TC2N;TIPARP;TM9SF3;TMEM2;TMEM50B;USP8;VPS13C;ZDHHC15;ZNF618 | ||
| 9 | |
geneSet | cisbp__M2978 | 3.60 | 0.0639 | ATF6 (directAnnotation). | ATF6B; CREB3; CREB3L1; CREB3L4 (inferredBy_MotifSimilarity). CREB3L2 (inferredBy_MotifSimilarity_n_Orthology). | 31 | 638 | APBB2;C2orf27A;CKMT2;CLCN3;CLP1;CNTN6;DDX17;EFNB1;EHF;GK;HDDC2;HDX;HIVEP2;HOXB3;ITGA2;LRRC32;MORF4L2;NAMPT;NDUFA10;PALLD;PTPRM;RNF19A;SCFD1;SEL1L3;SFRP4;SGMS1;SLC39A10;SYT11;TM9SF3;WSB1;ZNF595 |
| 10 | |
geneSet | cisbp__M4886 | 3.60 | 0.0639 | 31 | 625 | APBB2;C2orf27A;CKMT2;CLCN3;CRADD;CRHBP;CTBP2;DDIT4;DDX17;EDA;FAM46A;LRIG1;MEIS2;NPAS2;OSBPL1A;PALLD;PCDH9;PDXK;PER2;PICALM;POLH;PRRX1;RNMT;SERPINE1;SGMS1;SYT11;VPS13A;WLS;WRB;ZNF131;ZNF835 |
NA
| X | logo | geneSet | motif | NES | AUC | TF_highConf | TF_lowConf | nEnrGenes | rankAtMax | enrichedGenes |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 |  |
geneSet | dbcorrdb__GABPA__ENCSR000BLO_1__m1 | 5.22 | 0.172 | GABPA (directAnnotation). | BCLAF1; CREB1; E2F4; E2F6; EGR1; ELF1; ELF2; ELF4; ELK1; ELK3; ELK4; ERF; ERG; ESRRA; ETS1; ETS2; ETV1; ETV2; ETV3; ETV4; ETV5; ETV6; EZH2; FEV; FLI1; FOXP2; GABPB1; HCFC1; IRF1; KDM5A; KDM5B; MAX; MXI1; MYC; NR2C2; PHF8; PML; POLR2A; RBBP5; RELA; SIN3A; SMARCA4; SREBF1; SREBF2; SRF; SUPT20H; TAF1; UBTF; XRCC4; ZMIZ1; ZNF143; ZNF274 (inferredBy_MotifSimilarity). ETV3L; ETV7 (inferredBy_MotifSimilarity_n_Orthology). | 10 | 941 | CD2BP2;CSNK1G2;FAM120B;GATAD2A;KIAA1919;MAP7D1;NOSIP;PRKD2;USP19;ZBTB6 |
| 2 |  |
geneSet | dbcorrdb__GABPA__ENCSR000BPY_1__m1 | 5.05 | 0.168 | GABPA (directAnnotation). | BCLAF1; BHLHE40; CTCF; EGR1; ELF1; ELF2; ELK1; ELK3; ELK4; ERF; ERG; ESRRA; ETS1; ETV1; ETV2; ETV3; ETV4; ETV5; EZH2; FEV; FLI1; GABPB1; HCFC1; MAX; MXI1; MYC; PHF8; PML; POLR2A; SIN3A; SRF; TAF1; XRCC4; YY1; ZNF143 (inferredBy_MotifSimilarity). ETS2; ETV3L; ETV6; ETV7 (inferredBy_MotifSimilarity_n_Orthology). | 8 | 527 | CD2BP2;CSNK1G2;FAM120B;KIAA1919;MAP7D1;NOSIP;USP19;ZBTB6 |
| 3 |  |
geneSet | dbcorrdb__ELK1__ENCSR000DZB_1__m1 | 4.92 | 0.164 | ELK1 (directAnnotation). | BCLAF1; BHLHE40; BRF2; CTCF; EGR1; ELF1; ELK3; ELK4; ERF; ERG; ESRRA; ETS1; ETS2; ETV1; ETV2; ETV3; ETV4; ETV5; EZH2; FEV; FLI1; GABPA; GABPB1; HCFC1; MAX; MXI1; MYC; PHF8; PML; POLR2A; SIN3A; SRF; TAF1; XRCC4; YY1; ZMIZ1; ZNF143 (inferredBy_MotifSimilarity). ETV3L; ETV6; ETV7 (inferredBy_MotifSimilarity_n_Orthology). | 9 | 755 | CD2BP2;CSNK1G2;FAM120B;GATAD2A;KIAA1919;MAP7D1;NOSIP;USP19;ZBTB6 |
| 4 |  |
geneSet | transfac_pro__M01258 | 4.85 | 0.163 | BCLAF1; EGR1; ELF1; ELF2; ELF4; ELF5; ELK1; ELK3; ELK4; ERF; ERG; ETS1; ETS2; ETV1; ETV2; ETV3; ETV4; ETV5; ETV6; FEV; FLI1; GABPA; GABPB1; HCFC1; NR2C2; PHF8; PML; POLR2A; RBBP5; SIN3A; SRF; TAF1 (inferredBy_MotifSimilarity). ETV3L; ETV7 (inferredBy_MotifSimilarity_n_Orthology). | 8 | 497 | CD2BP2;FAM120B;GATAD2A;KIAA1919;MAP7D1;NOSIP;USP19;ZBTB6 | |
| 5 |  |
geneSet | cisbp__M4998 | 4.79 | 0.161 | ZNF513 (inferredBy_Orthology). | ZNF362; ZNF384 (inferredBy_MotifSimilarity_n_Orthology). | 6 | 153 | CSNK1G2;GATAD2A;GCNT1;GIMAP2;MYADM;NACC1 |
| 6 |  |
geneSet | homer__AACCGGAAGT_GABPA | 4.78 | 0.161 | GABPA (directAnnotation). | BCLAF1; ELF1; ELF2; ELF4; ELK1; ELK3; ELK4; ERF; ERG; ETS1; ETS2; ETV1; ETV2; ETV3; ETV4; ETV5; FEV; FLI1; GABPB1; RELA; SRF (inferredBy_MotifSimilarity). ETV3L; ETV6; ETV7 (inferredBy_MotifSimilarity_n_Orthology). | 9 | 755 | CD2BP2;CSNK1G2;FAM120B;GATAD2A;KIAA1919;MAP7D1;NOSIP;USP19;ZBTB6 |
| 7 |  |
geneSet | transfac_pro__M01987 | 4.77 | 0.161 | ETV1 (inferredBy_Orthology). | BCLAF1; ELF1; ELF2; ELF4; ELF5; ELK1; ELK3; ELK4; ERF; ERG; ETS1; ETS2; ETV2; ETV3; ETV4; ETV5; ETV6; FEV; FLI1; GABPA; GABPB1; PML; POLR2A; SPDEF; SRF; TAF1 (inferredBy_MotifSimilarity). ETV3L; ETV7 (inferredBy_MotifSimilarity_n_Orthology). | 8 | 675 | CD2BP2;CSNK1G2;FAM120B;KIAA1919;MAP7D1;NOSIP;USP19;ZBTB6 |
| 8 |  |
geneSet | dbcorrdb__ELF1__ENCSR000BMB_1__m1 | 4.71 | 0.159 | ELF1 (directAnnotation). | BCLAF1; E2F4; E2F6; EGR1; EHF; ELF2; ELF4; ELF5; ELK1; ELK3; ELK4; ERG; ETS1; ETV2; ETV6; EZH2; FOXP2; GABPA; GABPB1; HCFC1; IRF1; MXI1; MYC; NR2C2; PHF8; PML; POLR2A; RBBP5; RELA; SIN3A; SMARCA4; SREBF1; SREBF2; SRF; TAF1; XRCC4; ZNF143; ZNF274 (inferredBy_MotifSimilarity). ERF; ETV3; ETV3L; FLI1 (inferredBy_MotifSimilarity_n_Orthology). | 8 | 492 | CD2BP2;CSNK1G2;FAM120B;GATAD2A;KIAA1919;MAP7D1;NOSIP;ZBTB6 |
| 9 |  |
geneSet | taipale_tf_pairs__ETS2_RCCGGAAGTG_HT | 4.70 | 0.159 | ETS2 (directAnnotation). | 8 | 449 | CD2BP2;FAM120B;GATAD2A;KIAA1919;MAP7D1;NOSIP;USP19;ZBTB6 | |
| 10 |  |
geneSet | transfac_pro__M07706 | 4.63 | 0.157 | ETV2 (inferredBy_Orthology). | BCLAF1; EGR1; ELF1; ELF2; ELF4; ELK1; ELK3; ELK4; ERF; ERG; ETS1; ETS2; ETV1; ETV3; ETV4; ETV5; FEV; FLI1; GABPA; GABPB1; PML; SRF; TAF1 (inferredBy_MotifSimilarity). ETV3L; ETV6; ETV7 (inferredBy_MotifSimilarity_n_Orthology). | 8 | 600 | CD2BP2;CSNK1G2;FAM120B;KIAA1919;MAP7D1;NOSIP;USP19;ZBTB6 |